Wholesalers Benefit From Fee-Based Contracts, But Speculative Buying Not Extinct
Shifting to fee-for-service agreements with pharmaceutical companies has benefited wholesalers improving cash flow, although it appears they have not entirely abandoned speculative buying
You may also be interested in...
AmerisourceBergen expects pharmaceutical manufacturer inventory destocking observed during the first quarter of 2005 to continue through the year
Adiana uses a polymer matrix insert to block the fallopian tubes instead of a metal coil, offering a benefit over Essure, which carries a perforation risk on implantation, Hologic exec says.
The results show that cardiac resynchronization defibrillators "slow the progression of heart failure in asymptomatic and mildly symptomatic patients," potentially expanding the market by $600 million.